AMPH Amphastar Pharmaceuticals, Inc.
Stock · NasdaqGS · United States · Healthcare · US03209R1032
NowoTrade is an independent information site. It is not affiliated with, endorsed by or sponsored by Amphastar Pharmaceuticals, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price
28.49 USD
+3.00%
52-week range
16.65 – 31.00
Dividend yield—
Market cap1.2B
NowoTrade score
49 Grade A
Price history
Daily prices in USD.
Updated 08 Nov 2026 14:54. Information, not advice.
Results
Next results
25 Feb 2027
in 109 days · 16:00 · estimate 0.79
Last results
1.14 vs 0.86 estimated
05 Nov 2026 · Beat +32.8%
Beat the estimate
7 of 12
5 missed · 0 in line · 2 beats in a row
Average surprise
+8.7%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 25 Feb 2027 16:00 | 0.79 | — | — | Upcoming |
| 05 Nov 2026 16:00 | 0.86 | 1.14 | +32.8% | Beat |
| 06 Aug 2026 16:00 | 0.61 | 0.91 | +48.3% | Beat |
| 07 May 2026 16:00 | 0.71 | 0.42 | -40.5% | Miss |
| 26 Feb 2026 16:00 | 0.92 | 0.73 | -20.5% | Miss |
| 06 Nov 2025 16:00 | 0.83 | 0.93 | +12.7% | Beat |
| 07 Aug 2025 16:00 | 0.74 | 0.85 | +14.6% | Beat |
| 07 May 2025 16:00 | 0.69 | 0.74 | +7.6% | Beat |
| 27 Feb 2025 16:00 | 0.94 | 0.92 | -2.0% | Miss |
| 06 Nov 2024 16:00 | 0.98 | 0.96 | -2.1% | Miss |
| 07 Aug 2024 16:00 | 0.75 | 0.94 | +25.1% | Beat |
| 08 May 2024 16:00 | 0.79 | 1.04 | +32.2% | Beat |
| 28 Feb 2024 16:00 | 0.91 | 0.88 | -3.3% | Miss |
| 08 Nov 2023 16:00 | 0.69 | 1.15 | +66.7% | Beat |
| 08 Aug 2023 16:00 | 0.56 | 0.65 | +16.1% | Beat |
| 09 May 2023 16:00 | 0.50 | 0.62 | +25.3% | Beat |
| 28 Feb 2023 16:00 | 0.40 | 0.73 | +82.5% | Beat |
| 07 Nov 2022 16:00 | 0.39 | 0.38 | -3.4% | Miss |
| 08 Aug 2022 16:00 | 0.35 | 0.39 | +12.1% | Beat |
| 09 May 2022 16:00 | 0.36 | 0.47 | +30.6% | Beat |
| 10 Mar 2022 16:00 | 0.37 | 0.42 | +13.5% | Beat |
| 08 Nov 2021 16:00 | 0.23 | 0.46 | +100.0% | Beat |
| 09 Aug 2021 16:00 | 0.21 | 0.21 | +0.8% | In line |
| 06 May 2021 16:00 | 0.18 | 0.27 | +46.5% | Beat |
| 15 Mar 2021 16:00 | 0.14 | 0.16 | +16.7% | Beat |
| 06 Nov 2020 06:00 | 0.14 | 0.15 | +7.1% | Beat |
| 06 Aug 2020 16:00 | 0.14 | 0.16 | +17.9% | Beat |
| 07 May 2020 17:00 | 0.09 | 0.17 | +98.3% | Beat |
| 12 Mar 2020 16:00 | 0.08 | 0.07 | -6.7% | Miss |
| 07 Nov 2019 16:00 | 0.07 | 0.10 | +50.0% | Beat |
| 07 Aug 2019 16:00 | 0.05 | 0.08 | +53.3% | Beat |
| 09 May 2019 16:00 | 0.05 | 0.10 | +85.2% | Beat |
| 12 Mar 2019 16:00 | 0.11 | 0.13 | +18.2% | Beat |
| 08 Nov 2018 16:00 | 0.11 | 0.12 | +9.1% | Beat |
| 08 Aug 2018 16:00 | 0.08 | 0.03 | -62.5% | Miss |
| 09 May 2018 16:00 | 0.08 | -0.05 | -166.7% | Miss |
| 12 Mar 2018 16:00 | 0.07 | 0.10 | +50.0% | Beat |
| 08 Nov 2017 16:00 | 0.03 | 0.07 | +118.8% | Beat |
| 09 Aug 2017 16:00 | 0.07 | 0.11 | +53.5% | Beat |
| 08 May 2017 16:00 | 0.08 | 0.09 | +15.4% | Beat |
| 13 Mar 2017 16:00 | 0.04 | 0.01 | -75.0% | Miss |
| 08 Nov 2016 16:00 | 0.08 | 0.14 | +69.7% | Beat |
| 08 Aug 2016 16:00 | 0.04 | 0.23 | +475.0% | Beat |
| 09 May 2016 16:00 | -0.03 | 0.12 | +469.2% | Beat |
| 14 Mar 2016 16:00 | -0.04 | 0.19 | +642.9% | Beat |
| 12 Nov 2015 16:00 | -0.08 | -0.01 | +87.5% | Beat |
| 12 Aug 2015 16:00 | -0.13 | -0.09 | +30.8% | Beat |
| 13 May 2015 06:00 | -0.06 | -0.01 | +83.3% | Beat |
| 24 Mar 2015 16:00 | -0.06 | -0.03 | +50.0% | Beat |
| 12 Nov 2014 16:00 | -0.09 | -0.07 | +19.2% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 719.9M | -1.7% | 98.1M | 13.6% | 2.03 | -33.7% | 119M |
| 2024 | 732M | +13.6% | 159.5M | 21.8% | 3.06 | +17.7% | 172.3M |
| 2023 | 644.4M | +29.1% | 137.5M | 21.3% | 2.60 | +49.4% | 145.3M |
| 2022 | 499M | — | 91.4M | 18.3% | 1.74 | — | 65.1M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 04 Apr 2025 | 26.34 | 27.02 | 26.14 | 26.61 | -2.31% | 699,400 | |
| 03 Apr 2025 | 27.67 | 28.06 | 26.88 | 27.24 | -2.01% | 605,700 | |
| 02 Apr 2025 | 27.99 | 28.29 | 27.02 | 27.80 | -1.73% | 717,800 | |
| 01 Apr 2025 | 28.86 | 29.27 | 28.17 | 28.29 | -2.41% | 785,100 | |
| 31 Mar 2025 | 28.22 | 29.18 | 28.01 | 28.99 | +1.97% | 547,900 | |
| 28 Mar 2025 | 28.45 | 28.71 | 28.23 | 28.43 | -0.25% | 386,800 | |
| 27 Mar 2025 | 28.37 | 28.75 | 28.26 | 28.50 | +0.46% | 457,500 | |
| 26 Mar 2025 | 28.40 | 28.83 | 28.02 | 28.37 | -0.07% | 437,900 | |
| 25 Mar 2025 | 28.50 | 28.66 | 27.80 | 28.39 | -0.25% | 713,200 | |
| 24 Mar 2025 | 28.50 | 28.65 | 28.07 | 28.46 | +0.60% | 538,400 | |
| 21 Mar 2025 | 27.66 | 28.44 | 27.66 | 28.29 | +1.36% | 1,478,700 | |
| 20 Mar 2025 | 27.72 | 28.38 | 27.69 | 27.91 | +0.18% | 407,000 | |
| 19 Mar 2025 | 27.40 | 27.87 | 27.09 | 27.86 | +1.83% | 471,500 | |
| 18 Mar 2025 | 27.50 | 27.81 | 27.22 | 27.36 | -1.19% | 602,500 | |
| 17 Mar 2025 | 26.68 | 27.98 | 26.68 | 27.69 | +3.86% | 648,300 | |
| 14 Mar 2025 | 26.22 | 26.76 | 26.14 | 26.66 | +1.60% | 500,700 | |
| 13 Mar 2025 | 26.34 | 26.86 | 25.89 | 26.24 | -0.15% | 467,600 | |
| 12 Mar 2025 | 27.35 | 27.55 | 26.22 | 26.28 | -3.84% | 700,400 | |
| 11 Mar 2025 | 28.40 | 28.40 | 27.25 | 27.33 | -3.80% | 515,800 | |
| 10 Mar 2025 | 28.64 | 29.34 | 28.22 | 28.41 | -1.39% | 537,000 | |
| 07 Mar 2025 | 28.14 | 29.37 | 28.08 | 28.81 | +1.73% | 544,300 | |
| 06 Mar 2025 | 27.80 | 28.49 | 27.26 | 28.32 | +0.93% | 721,300 | |
| 05 Mar 2025 | 27.52 | 28.06 | 27.04 | 28.06 | +1.59% | 632,400 | |
| 04 Mar 2025 | 27.21 | 28.24 | 27.00 | 27.62 | +0.36% | 803,200 | |
| 03 Mar 2025 | 28.51 | 29.10 | 26.98 | 27.52 | -3.20% | 999,400 |
Page 17 of 51
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Should Earnings Beat Require Action From Amphastar Pharmaceuticals (AMPH) Investors? (opens in a new tab) Simply Wall St. · 07 Nov 2026 16:12
- Amphastar Pharmaceuticals, Inc. (AMPH) Q3 2026 Earnings Call Transcript (opens in a new tab) SeekingAlpha · 06 Nov 2026 18:04
- Amphastar (AMPH) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 06 Nov 2026 16:28
- Wells Fargo Maintains Equal-Weight on Amphastar Pharma, Raises Price Target to $25 (opens in a new tab) Benzinga · 06 Nov 2026 10:47
- Amphastar Pharmaceuticals Inc (AMPH) Q3 2026 Earnings Call Highlights: Record Revenue of $207. ... (opens in a new tab) GuruFocus.com · 06 Nov 2026 07:20
- Amphastar Pharmaceuticals Q3 Earnings Call Highlights (opens in a new tab) MarketBeat · 06 Nov 2026 00:14
- Amphastar Pharmaceuticals (NASDAQ:AMPH) Beats Q3 2026 Revenue and EPS Estimates (opens in a new tab) ChartMill · 05 Nov 2026 23:10
- Amphastar (AMPH) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (opens in a new tab) Zacks · 05 Nov 2026 22:30
- Amphastar Pharmaceuticals (NASDAQ:AMPH) reports bullish Q3 2026, stock soars (opens in a new tab) StockStory · 05 Nov 2026 22:16
- Amphastar Pharmaceuticals (AMPH) Tops Q3 Earnings and Revenue Estimates (opens in a new tab) Zacks · 05 Nov 2026 21:45
- Amphastar: Q3 Earnings Snapshot (opens in a new tab) Associated Press · 05 Nov 2026 21:39
- Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2026 (opens in a new tab) 05 Nov 2026 21:10
- Amphastar Pharma Q3 Adj. EPS $1.14 Beats $0.86 Estimate, Sales $207.608M Beat $197.852M Estimate (opens in a new tab) Benzinga · 05 Nov 2026 17:12
- Analysts Estimate Amphastar Pharmaceuticals (AMPH) to Report a Decline in Earnings: What to Look Out for (opens in a new tab) Zacks · 29 Oct 2026 13:00
- Amphastar Pharmaceuticals (AMPH) Stock Looks About Right After A 42% Slide (opens in a new tab) Simply Wall St. · 17 Oct 2026 02:11
Headlines link to the original articles of the publishers shown; NowoTrade does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 27.66 USD
- Market cap
- 1.2B
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- USD
Dividends
No dividends on record.
Why this score
| Part of the score | Points | Why |
|---|---|---|
| Business growth Yearly growth of revenue and of earnings per share. | 15.2 / 25 |
|
| Quality Return on equity, net margin and how stable the margins are. | 15.8 / 25 |
|
| Financial strength Net debt against operating earnings, interest cover and free cash flow. | 13.4 / 20 |
|
| Valuation Free cash flow yield and the P/E against its sector. | 8.4 / 15 |
|
| Analysts How far the analysts' average target is from today's price. | 0.0 / 10 |
|
- Total debt has risen three years in a row
Growth profile: it pays no dividend, so it is scored on business growth, quality and financial strength. Based on 95% of the figures (grade A). Warnings take 6 points off.
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio.
Figures
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| P/E (trailing) | 13.07× | Good | 30.65× |
| P/E (forward) | 8.98× | Good | 14.89× |
| Price / book | 1.49× | Good | 3.8× |
| Price / sales | 1.63× | Good | 3.19× |
| EV / EBITDA | 8.45× | Good | 12.61× |
| Free cash flow yield | 0.8% | Weak | 2.5% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Gross margin | 46.8% | Good | 58.6% |
| Operating margin | 24.5% | Good | 7.6% |
| Net margin | 13.3% | Good | 2.7% |
| Return on equity | 12.4% | Fair | 5.7% |
| Return on assets | 5.2% | Fair | 3.5% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Revenue growth / year | 13% | Good | 10.8% |
| EPS growth / year | 5.3% | Fair | 9.1% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Debt / equity | 0.85× | Fair | 0.48× |
| Net debt / EBITDA | 2.32× | Fair | 1.6× |
| Interest cover | 5.51× | Fair | 2.65× |
| Current ratio | 3.32× | Good | 2.36× |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Payout of earnings | 0% | Weak | 0% |
The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.
Follow AMPH and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.